Nature 276, 90 - 92 (02 November 1978); doi:10.1038/276090a0

Plasmid-determined tetracycline resistance involves new transport systems for tetracycline

STUART B. LEVY & LAURA MCMURRY

Departments of Molecular Biology and Microbiology and of Medicine, Tufts University School of Medicine, Boston, Massachusetts 02111

TETRACYCLINES are broad-spectrum bacteriostatic antibiotics which act by inhibiting protein synthesis^1,2. However, their usefulness in combating bacterial infection has been sharply curtailed by the widespread occurrence in bacteria of tetracycline resistance encoded by genes located on extrachromosomal DNA elements called plasmids^3,4. In many bacteria, notably Enterobacteriaceae, Pseudomonas and Staphylococcus, plasmid-mediated tetracycline resistance is inducible; the resistance level can be increased by preincubation of the cells in sub-inhibitory amounts of tetracycline⁵⁻⁸. Coincident with induced resistance is the induced synthesis of a plasmid-encoded inner membrane protein which we have designated TET protein⁸⁻¹⁰. Synthesis of this protein (and presumably most of the resistance determinant) is negatively regulated; a represser has been partially purified¹¹. However, the mechanisms for plasmid-mediated tetracycline resistance are not yet clear, and there seems to be no degradation of the antibiotic in resistant cells^10,12,13. Although resistant cells accumulate less tetracycline than do sensitive cells^14,15, the moderately reduced uptake does not explain the much larger difference in sensitivity to the drug^10,16,17. We report here that plasmid-containing resistant cells take up tetracycline by a different transport mechanism from that of sensitive cells. This altered transport seems to be responsible for at least part of the difference in tetracycline inhibition of sensitive as compared to resistant cells.

References

1.	Suzuki, I., Kaji, H. & Kaji, A. Proc. natn. Acad. Sci. U.S.A. 55, 1483–1490 (1966).
2.	Högenauer, G. & Turnowsky, F. FEBS Lett. 26, 185–188 (1972).
3.	Watanabe, T. Bact. Rev. 27, 87–115 (1963).
4.	Falkow, S. Infectious Multiple Drug Resistance (Pion, London, 1975).
5.	Izaki, K., Kiuchi, K. & Arima, K. J. Bact. 91, 628–633 (1966).
6.	Unowsky, J. & Rachmeler, M. J. Bact. 92, 358–365 (1966).
7.	Franklin, T. J. Biochem. J. 105, 371–378 (1967).
8.	Levy, S. B. & McMurry, L. Biochem. biophys. Res. Commun. 56, 1060–1068 (1974).
9.	Levy, S. B. in Drug-inactivating Enzymes and Antibiotic Resistance (eds Mitsuhashi, Rosival & Krméry) 215–225 (Springer, Berlin, 1975).
10.	Levy, S. B., McMurry, L., Onigman, P. & Saunders, R. M. in Topics in Infectious Diseases, Vol. 2 (eds Drews & Högenauer) 180–203 (Springer, Berlin, 1977).
11.	Yang, H-L., Zubay, G. & Levy, S. B. Proc. natn. Acad. Sci. U.S.A. 73, 1509–1512 (1976).
12.	DeZeeuw, J. R. J. Bact. 95, 498–506 (1968).
13.	Sompolinsky, D., Krawitz, T., Zaidenzaig, Y. & Abramova, N. J. gen. Microbiol. 62, 341–349 (1970).
14.	Arima, K. & Izaki, K. Nature 200, 192–193 (1963).
15.	Franklin, T. J. & Godfrey, A. Biochem. J. 94, 54–60 (1965).
16.	Reynard, A. M., Nellis, L. F. & Beck, M. E. Appl. Microbiol. 21, 71–75 (1971).
17.	Levy, S. B. & McMurry, L. in Microbiology 1978 (ed. Schlessinger) 177–180 (Am. Soc. for Microbiol., Washington, 1978).
18.	McMurry, L. & Levy, S. B. Antimicrob. Ag. Chem. 14, 201–209 (1978).
19.	Foster, T. J., Howe, T. G. B. & Richmond, K. M. V. J. Bact. 124, 1153–1158 (1975).
20.	Lehninger, A. L. Biochemistry, 429 (North, New York, 1975).
21.	Berger, E. A. & Heppel, L. A. J. biol. Chem. 249, 7747–7755 (1974).
22.	Wilson, D. B. J. Bact. 126, 1156–1165 (1976).
23.	Levy, S. B. J. Bact. 108, 300–308 (Fig. 4) (1971).
24.	Lennox, E. S. Virology 1, 190–206 (1955).
25.	Curtiss, R. J. Bact. 89, 28–40 (1965).
26.	Heppel, L. A. in Structure and Function of Biological Membranes (ed. Rothfield) 223–247 (Academic, New York, 1971).
27.	Navashin, S. M., Beliavskaya, I. V., Sazykin, Y. O. & Gryaznova, N. S. in Drug-inactivating Enzymes and Antibiotic Resistance (eds Mitsuhashi, Rosival & Krméry), 227–230 (Springer, Berlin, 1975).